"Nuclear medicines, like radioligand therapy, could be transformative for cancer care in Australia. Establishing clear pathways for market access and a thriving nuclear medicine industry will be key to enabling Australian patients to access these new treatment options," said Novartis country president Matt Zeller. …
New Novartis-backed report identifies nuclear medicine opportunity but calls for change
April 19, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
The term 'independent' is used to absolve decision-makers of responsibility
May 1, 2024 - - Latest News -
'The journey for people living with severe psoriasis can be long and difficult'
May 1, 2024 - - Latest News -
Pfizer welcomes PBS listing of therapy for rare heart condition
May 1, 2024 - - Latest News -
First in class therapy for obstructive hypertrophic cardiomyopathy now reimbursed
May 1, 2024 - - Latest News -
Summit's day one provided critical lessons for both sides of the Tasman
April 30, 2024 - - Latest News -
'Important for me to share the full picture as we must never allow it to happen again'
April 30, 2024 - - Latest News -
NZ Government commits new funding to address Pharmac's 'fiscal cliff'
April 29, 2024 - - Latest News